ABOUT THE JOURNAL

• About the journal
• Aims and scope of journal
• Impact factor
• Abstracted/indexed in
• ISSN and eISSN
• Editors

About the journal

Research on antibiotics and other microbial products is pivotal to the global battle against the growing problem of antibiotic resistance. As well as the traditional research and development model of finding replacement drugs to tackle this problem, there are other important new strategies for addressing resistance which include research into bioactive microbial products.

The Journal of Antibiotics forms an integral part of this battle against resistance by encouraging and publishing original research articles that report findings of wide biological significance in the multidisciplinary field of antimicrobials. We specifically encourage articles that represent important advances in the field of antimicrobial research, including recently discovered antibiotics, bioactive microbial products and novel strategies for combating antibiotic resistance. The Journal of Antibiotics provides a dynamic platform for communicating research on microbial products and antimicrobial approaches through also including insightful and up-to-date reviews, short communications and letters to the editor.

Aims and scope of journal

The Journal of Antibiotics seeks to promote research on antibiotics and related types of medicinal substances. The journal will accept biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal's scope. Contributions regarding antibiotics and bioactive microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below:

• Discovery of new antibiotics and related microbial products
• Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related microbial products
• Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related microbial products
• Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related microbial products
• Newly found properties, mechanisms of action and resistance-development of antibiotics and related microbial products

The Journal of Antibiotics's original articles cover new theories and primary research. The journal also publishes regular short reviews, book reviews, and news and commentary articles.

Impact factor

2008 Impact Factor: 1.272*

Rank:
100/144 in Biotechnology & Applied Microbiology*
105/121 in Immunology*
74/91 in Microbiology*
163/216 in Pharmacology & Pharmacy*

* Journal Citation Reports, Thomson Reuters 2009

Abstracted/indexed in

BIOSIS
ChemPort
Current Contents/Life Sciences
ISI
JDream II
PubMed
SCOPUS

ISSN and eISSN

The international standard serial number (ISSN) for The Journal of Antibiotics is 0021-8820, and the electronic international standard serial number (eISSN) is 1881-1469.

Editors

Editor-in-Chief

Satoshi Ōmura, The Kitasato Institute, Japan

Managing Editor

Yoshikazu Takahashi, Microbial Chemistry Research Center, Japan

Review Editors

Gerard D. Wright, McMaster Univ., Canada
Minoru Yoshida, RIKEN, Japan

Section Editors

New Anti-infective Substances
James B. McAlipine, Thallion Pharm. Inc., Canada
Hiroshi Tomoda, Kitasato Univ., Japan

New Bioactive Substances
Timm Anke, IBWF, Germany
Masaya Imoto, Keio Univ., Japan

Structure Determination/ Chemical Synthesis
Herbert A. Kirst, USA
Kuniaki Tatsuta, Waseda Univ, Japan

Chemical Biology/ Mode of Action/ Biological Activities
Claude H. Nash III, Bloodstone Ventures plc, USA
Hiroyuki Osada, RIKEN, Japan

Microbial Genetics/ Biosynthesis
David E. Cane, Brown Univ., USA
Haruo Ikeda, Kitasato University, Japan

Microbiology/ Fermentation/ Resistance
Prabhavathi B. Fernandes, Cempra Pharm. Inc., USA
Seiji Hashimoto, Toyama Prefect. Univ., USA

Editorial Board

Paul Actor, Paul Actor Associates, USA
János Bérdy, Hungary
Teruhiko Beppu, Nihon Univ., Japan
J. W. Blunt, Univ. Canterbury, New Zealand
André J. Brayskier, Aventis Phama., France
M. S. Butler, MerLion Pharm., Singapore
Guy T. Carter, Wyeth Res., USA
Giuseppe Cassinelli, G. Ronzoni Res. Ins., Italy
Yuan-Rong Cheng, Fujian Inst. Microb., China
Burton G. Christensen, USA
Min Chu, Cubist Pharm., Inc., USA
Robin D. G. Cooper, Rigel Inc., USA
Franco Cozzi, Univ. Milan., Italy
Eric Cundliffe, Univ. Leicester, UK
Mike Dawson, Novacta Biosystems Ltd., UK
Terrence W. Doyle, TWDoyle Consulting Inc., USA
T. Eguchi, Tokyo Inst. Tech., Japan
William Fenical, Univ. California, USA
Miroslav Flieger, Acad. Sci., Czech Republic
Yasuo Fukagawa, BIOSCIENCE ASSOC., Japan
Tamotsu Furumai, Japan
B. N. Ganguli, Univ. Bombay, India
Edmund I. Graziani, Wyeth Res., USA
Sueharu Horinouchi, Univ. Tokyo, Japan
Kunimoto Hotta, Functional Water Foundation, Japan
David R. Houck, MycoFuels Inc., USA
Liang H. Huang, USA
Daishiro Ikeda, Microb.Chem.Res.Center, Japan
Antonio Jimenez, Univ.Autónoma, Spain
Leonard Katz, USA
Chaitan Khosla, Stanford Univ., USA
Haruyasu Kinashi, Hiroshima Univ., Japan
Jun'ichi Kobayashi, Hokkaido Univ., Japan
Nakao Kojima, Meijo Univ., Japan
Karsten Krohn, Univ. Paderborn, Germany
Ming-Shang Kuo, Eli Lilly & Co., USA
Hartmut Laatsch, Univ. Goettingen, Germany
David P. Labeda, Nationa Center Agricultural Utilization Res., USA
Hubert Maehr, BIOXELL Inc., USA
Juan-Francisco Martin, Univ. León, Spain
Marvin J. Miller, Univ. Notre Dame, USA
B. S. Moore, Univ. California, U.S.A.
Takeshi Murakam, Meiji Seika Kaisha, Ltd., Japan
Hirofumi Nakano, Kitasato Inst., Japan
Yoshio Nishimura, Microb.Chem.Res.Center, Japan
Takeshi Ogita, Daiichi-Sankyo Co., Ltd., Japan
William L. Parker, Bristol-Myers Squibb Co., USA
Jacob J. Plattner, Anacor Pharm., USA
Maria N. Preobrazhenskaya, Gause Inst. New Antibiot., Russia
Sherry F. Queener, Indiana Univ. Sch .Med., USA
José A. Salas, Univ. Oviedo, Spain
B. Shen, Univ of Wisconsin, U.S.A.
K. Shiomi, Kitasato Univ., Japan
Sheo Singh, Merck Res. Lab., USA
Amos B. Smith, III, Univ. Pennsylvania, USA
Olov Sterner, Lund Univ., Sweden
Ferenc J. Sztaricskai, Univ. Debrecen, Hungary
Haruo Tanaka, Iwaki Meisei Univ., Japan
Dean P. Taylor, Iwaki Meisei Univ., USA
Yoshimasa Uehara, Iwate Med. Univ., Japan
Kazuo Umezawa, Keio Univ., Japan
Elizabeth Wellington, Univ.Warwick, UK
Stephen K. Wrigley, Hypha Discovery Ltd., UK
Raymond C. Yao, USA
Ick-Dong Yoo, KRIBB, Korea
Lixin Zhang, Chinese Acad. Sci., China
Jieping Zhu, CNRS, France
Franco Zunino, Inst. Nazionale Tumori., Italy